Brought to you by 
Adeza Biomedical nets $62.4mm with IPO
02 Feb 2005
Executive Summary
Adeza Biomedical (diagnostics for pregnancy-related and female reproductive disorders) netted $62.4mm (including the overallotment) with its initial public offering of 4.31mm shares priced at $16 each. The company originally filed for the offering in August.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Adeza Biomedical nets $62.4mm with IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice